Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jung Nam An

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Kidney Research and Clinical Practice|November 16, 2021
When and why to start continuous renal replacement therapy in critically ill patients with acute kidney injuryJung Nam An, Sung Gyun Kim, Young Rim Song
Kidney Research and Clinical Practice|March 25, 2026
Impact of early vs. late initiation of continuous renal replacement therapy on composite outcomes including acute kidney disease and mortality: a multicenter propensity-matched cohort study (LINKA cohort)Sei-Hong Min, Sung Gyun Kim, Jung Nam An, et al.
Kidney Research and Clinical Practice|September 8, 2025
Unmet clinical need in patients with acute kidney injury and acute kidney disease: insights from a Korean multicenter cohortJung Nam An, Donghwan Yun, Seung Seok Han, et al.
The Korean Journal of Internal Medicine|March 10, 2012
Induction of donor-specific tolerance: is this achievable?Eun Jin Cho, Ji In Park, Jung Nam An, et al.
Kidney Research and Clinical Practice|February 20, 2016
Laparoscopic biopsy-proven lupus nephritis in autosomal dominant polycystic kidney diseaseJi In Park, Hajeong Lee, Jung Nam An, et al.
Microorganisms|October 29, 2025
Immunogenicity and Breakthrough Outcomes of mRNA Booster Strategies Among Healthcare Workers During the BA.1/BA.2 Omicron SurgeSong Mi Moon, Jung Nam An, Jae Hyun Kwon, et al.
Hepatology International|June 20, 2020
Portal inflammation predicts renal dysfunction in patients with nonalcoholic fatty liver diseaseJung Nam An, Sae Kyung Joo, Bo Kyung Koo, et al.
Plos One|March 22, 2019
p38 MAPK activity is associated with the histological degree of interstitial fibrosis in IgA nephropathy patientsJeonghwan Lee, Jung Nam An, Jin Ho Hwang, et al.
Clinical Kidney Journal|October 29, 2025
Galectin-3 as a prognostic biomarker in haemodialysis patients with preserved or mildly reduced ejection fractionSei Hong Min, Insoo Kim, Jung Nam An, et al.
American Journal of Nephrology|August 18, 2024
Impact of Fat Mass on Osteoporosis, Sarcopenia, and Osteosarcopenia in Peritoneal Dialysis PatientsIn Soo Kim, Hyung Seok Lee, Jinha Jang, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Kidney Research and Clinical Practice|November 16, 2021
When and why to start continuous renal replacement therapy in critically ill patients with acute kidney injuryJung Nam An, Sung Gyun Kim, Young Rim Song
Kidney Research and Clinical Practice|March 25, 2026
Impact of early vs. late initiation of continuous renal replacement therapy on composite outcomes including acute kidney disease and mortality: a multicenter propensity-matched cohort study (LINKA cohort)Sei-Hong Min, Sung Gyun Kim, Jung Nam An, et al.
Kidney Research and Clinical Practice|September 8, 2025
Unmet clinical need in patients with acute kidney injury and acute kidney disease: insights from a Korean multicenter cohortJung Nam An, Donghwan Yun, Seung Seok Han, et al.
The Korean Journal of Internal Medicine|March 10, 2012
Induction of donor-specific tolerance: is this achievable?Eun Jin Cho, Ji In Park, Jung Nam An, et al.
Kidney Research and Clinical Practice|February 20, 2016
Laparoscopic biopsy-proven lupus nephritis in autosomal dominant polycystic kidney diseaseJi In Park, Hajeong Lee, Jung Nam An, et al.
Microorganisms|October 29, 2025
Immunogenicity and Breakthrough Outcomes of mRNA Booster Strategies Among Healthcare Workers During the BA.1/BA.2 Omicron SurgeSong Mi Moon, Jung Nam An, Jae Hyun Kwon, et al.
Hepatology International|June 20, 2020
Portal inflammation predicts renal dysfunction in patients with nonalcoholic fatty liver diseaseJung Nam An, Sae Kyung Joo, Bo Kyung Koo, et al.
Plos One|March 22, 2019
p38 MAPK activity is associated with the histological degree of interstitial fibrosis in IgA nephropathy patientsJeonghwan Lee, Jung Nam An, Jin Ho Hwang, et al.
Clinical Kidney Journal|October 29, 2025
Galectin-3 as a prognostic biomarker in haemodialysis patients with preserved or mildly reduced ejection fractionSei Hong Min, Insoo Kim, Jung Nam An, et al.
American Journal of Nephrology|August 18, 2024
Impact of Fat Mass on Osteoporosis, Sarcopenia, and Osteosarcopenia in Peritoneal Dialysis PatientsIn Soo Kim, Hyung Seok Lee, Jinha Jang, et al.
Pageof 10